Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Farmers Insurance
Harvard Business School
Fuji
Cantor Fitzgerald
US Army
Dow
Teva
Boehringer Ingelheim
Johnson and Johnson

Generated: February 23, 2018

DrugPatentWatch Database Preview

Chartwell Rx Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has forty-seven approved drugs.



Summary for Chartwell Rx
US Patents:0
Tradenames:25
Ingredients:22
NDAs:47

Drugs and US Patents for Chartwell Rx

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx FULVICIN P/G 330 griseofulvin, ultramicrocrystalline TABLET;ORAL 061996-004 Apr 6, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 086732-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085761-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx FULVICIN P/G griseofulvin, ultramicrocrystalline TABLET;ORAL 061996-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; moexipril hydrochloride TABLET;ORAL 090096-002 Sep 25, 2008 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 083965-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 085319-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 083923-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx PREDNISOLONE prednisolone TABLET;ORAL 084542-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Chartwell Rx CAM-METRAZINE phendimetrazine tartrate TABLET;ORAL 085320-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
US Army
Johnson and Johnson
Moodys
Cerilliant
Dow
Merck
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot